
Colimista 4.5MIU Injection
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Colistimethate Sodium (4.5Million IU)
Overview Colimista 4.5MIU Injection
Colimista 4.5MIU Injection, an antibacterial agent, combats severe systemic bacterial infections. Primarily administered to critically ill hospitalized patients, it requires the oversight of a healthcare provider; self-administration is strictly prohibited. Dosage and treatment length are determined by your physician, considering infection severity and type. Consistent administration, as directed, maximizes therapeutic efficacy. Potential adverse reactions may encompass gastrointestinal distress, dysarthria, lightheadedness, vertigo, pyrexia, dermatological reactions, and paresthesia. These are often transient, resolving with continued treatment. Persistent or bothersome side effects necessitate medical consultation. Prior to commencing therapy, disclose any antibiotic allergies, hepatic or renal impairments. Pregnant or lactating individuals must seek medical counsel before use. Regular blood tests to monitor renal function and drug levels may be implemented by your physician.
Uses of Colimista 4.5MIU Injection
Life-threatening bacterial infections
Major Benefits of Colimista 4.5MIU Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Colimista 4.5MIU Injection:
- Slurred speech
- Upset stomach
- Dizziness
- Gastrointestinal disturbance
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Rash
- Fever
- Generalized itching
- Red spots or bumps
- Increased blood urea nitrogen
- Increased creatinine level in blood
- Decreased creatinine clearance
- Respiratory distress
- Apnea (absence of breathing)
- Renal toxicity
- Decreased urinary volume
How to use Colimista 4.5MIU Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Colimista 4.5MIU Injection works:
Colimista 4.5MIU Injection, an antibacterial agent, functions by disrupting bacterial cell membranes, leading to bacterial death.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Colimista 4.5MIU Injection.
PregnancyCONSULT YOUR DOCTOR
The use of Colimista 4.5MIU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Colimista 4.5MIU Injection without significant risk to their infants. Available data from human studies indicate minimal danger to the baby.
DrivingUNSAFE
Administering Colimista 4.5MIU Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCAUTION
For individuals with kidney impairment, administering Colimista 4.5MIU Injection requires careful consideration. A modified dosage of Colimista 4.5MIU Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Colimista 4.5MIU Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Colimista 4.5MIU Injection :
NA
Facts to Know About Colimista 4.5MIU Injection
Label | Value |
---|---|
Chemical Category | Peptide chains |
Developing Habits | No. |
Treatment Category | Antimicrobial Agents |